Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome

[1]  P. Nilsson,et al.  Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. , 2021, JAMA.

[2]  D. Brodie,et al.  Post-acute COVID-19 syndrome , 2021, Nature Medicine.

[3]  M. Ståhlberg,et al.  Long-Haul Post–COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrome , 2021, JACC: Case Reports.

[4]  M. Brady,et al.  Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study , 2021, BMJ Open.

[5]  P. Taub,et al.  Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome. , 2021, Journal of the American College of Cardiology.

[6]  P. Kellman,et al.  Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance , 2021, European heart journal.

[7]  J. Tyberg,et al.  Compression Garment Reduces Orthostatic Tachycardia and Symptoms in Patients With Postural Orthostatic Tachycardia Syndrome. , 2021, Journal of the American College of Cardiology.

[8]  Guohui Fan,et al.  RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2021, The Lancet.

[9]  S. Yong.  Long-Haul COVID-19: Putative Pathophysiology, Risk Factors, and Treatments , 2020 .

[10]  J. van der Linden,et al.  Thromboembolism, Hypercoagulopathy, and Antiphospholipid Antibodies in Critically Ill Coronavirus Disease 2019 Patients: A Before and After Study of Enhanced Anticoagulation , 2020, Critical care explorations.

[11]  M. Jenkinson,et al.  Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge , 2020, EClinicalMedicine.

[12]  S. Jaradeh,et al.  A case report of postural tachycardia syndrome after COVID-19 , 2020, Clinical Autonomic Research.

[13]  T. Pillay,et al.  Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2) , 2020, Journal of Clinical Pathology.

[14]  M. Persson,et al.  Serum Activity Against G Protein–Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia Syndrome , 2020, Journal of the American Heart Association.

[15]  Eike Nagel,et al.  Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[16]  Yanfeng Gao,et al.  Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery , 2020, EClinicalMedicine.

[17]  H. Krumholz,et al.  Extrapulmonary manifestations of COVID-19 , 2020, Nature Medicine.

[18]  L. Stiles,et al.  Autoimmunity in postural orthostatic tachycardia syndrome: Current understanding , 2018, Autonomic Neuroscience.

[19]  A. Fedorowski.  Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management , 2018, Journal of internal medicine.

[20]  B. Olshansky,et al.  Inappropriate sinus tachycardia , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[21]  R. Cappato,et al.  A gain-of-function mutation in the cardiac pacemaker HCN4 channel increasing cAMP sensitivity is associated with familial Inappropriate Sinus Tachycardia , 2017, European heart journal.

[22]  Robert S Sheldon,et al.  2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. , 2015, Heart rhythm.

[23]  J. Kaski,et al.  Faculty Opinions recommendation of 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. , 2015 .

[24]  S. Raj,et al.  Hyperadrenergic Postural Tachycardia Syndrome in Mast Cell Activation Disorders , 2005, Hypertension.

[25]  A. Ertl,et al.  The neuropathic postural tachycardia syndrome. , 2000, The New England journal of medicine.

[26]  P. Low,et al.  Idiopathic postural orthostatic tachycardia syndrome , 1993, Neurology.